2015
DOI: 10.1016/j.cbi.2015.06.018
|View full text |Cite
|
Sign up to set email alerts
|

Identification and characterization of reactive metabolites in myristicin-mediated mechanism-based inhibition of CYP1A2

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
31
2

Year Published

2016
2016
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 33 publications
(33 citation statements)
references
References 41 publications
0
31
2
Order By: Relevance
“…The discrepancy in this effect could be explained by the relatively long incubation time in the cell migration assay (90 min) compared with the [Ca 2+ ] i flux assay (<5 min). Indeed, myristicin, like other allyl-benzenes, can form covalent conjugates with macromolecules during its enzymatic bioconversion 50 . In addition, the activation of neutrophil migration via FPR1 and CXCR1/2 could be independent of TRPV1 channels.…”
Section: Discussionmentioning
confidence: 99%
“…The discrepancy in this effect could be explained by the relatively long incubation time in the cell migration assay (90 min) compared with the [Ca 2+ ] i flux assay (<5 min). Indeed, myristicin, like other allyl-benzenes, can form covalent conjugates with macromolecules during its enzymatic bioconversion 50 . In addition, the activation of neutrophil migration via FPR1 and CXCR1/2 could be independent of TRPV1 channels.…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, the methyenedioxy group in myristicin is oxidized to an o -quinone leading to mechanism-based inhibition of P4501A2. 103 GSH was shown to block the inhibition which suggests that the o -quinone was the inhibitor and not the carbene formed from the methylenedioxy moiety. 103 The SSRI paroxetine was shown to be an inhibitor of P450 2D6, and the o -quinone metabolite was implicated as the reactive intermediate responsible for the inhibitory effect which ultimately leads to clinical drug–drug interactions with other P450 2D6 substrates.…”
Section: Quinone Targets (Figures 5 and 6)mentioning
confidence: 96%
“…130 Several drugs, environmental chemicals, natural products, and endogenous compounds form quinone GSH conjugates and/or cause GSH depletion. 3,10,70,79,92,103,105,106,109,121,141149 …”
Section: Quinone Targets (Figures 5 and 6)mentioning
confidence: 99%
See 1 more Smart Citation
“…4 We can also find myristicin in fennel, celery, and parsley plants. 5 Myristicin is also potential as an effective chemoprotective agent against cancer and hepatoprotective activity. 6,7 Myristicin is a derivative of phenylpropanoid compounds, in the form of a clear liquid, not soluble in water but soluble in organic solvents.…”
Section: Myristicinmentioning
confidence: 99%